Clinical trials can be expensive, but they don’t have to derail your budget. By partnering with Linear in Australia, you can take advantage of one of the most cost-effective clinical trial ecosystems in the world, without compromising on data quality or compliance.

Australia’s generous Refundable R&D Tax Incentive turns clinical trial spend into immediate cash flow with a 43.5% rebate on eligible trial costs.

At Linear, we help international biotech and pharma companies capitalise on this financial advantage while delivering high-quality, early-phase research with speed and precision.

Combine this with world-class infrastructure, FDA-recognised quality standards, and faster study startup, and you’ve got an unbeatable formula for biotech success.